Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.
Lucijanic M, Krecak I, Galusic D, Holik H, Perisa V, Moric Peric M, Zekanovic I, Budimir J, Lekovic D, Kusec R. Lucijanic M, et al. Among authors: moric peric m. Ann Hematol. 2024 Apr 23. doi: 10.1007/s00277-024-05751-7. Online ahead of print. Ann Hematol. 2024. PMID: 38652241 No abstract available.
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).
Hude Dragičević I, Bašić-Kinda S, Markotić H, Morić-Perić M, Dujmović D, Radman I, Dreta B, Dotlić S, Ilić I, Galunić Bilić L, Dobrenić M, Kralik M, Aurer I. Hude Dragičević I, et al. Among authors: moric peric m. Medicina (Kaunas). 2024 Mar 2;60(3):430. doi: 10.3390/medicina60030430. Medicina (Kaunas). 2024. PMID: 38541156 Free PMC article.
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases.
Aurer I, Jakšić O, Bašić-Kinda S, Mrđenović S, Ostojić-Kolonić S, Lozić D, Holik H, Novaković-Coha S, Berneš P, Krečak I, Morić-Perić M, Narančić M, Mitrović Z, Valković T. Aurer I, et al. Among authors: moric peric m. Biomedicines. 2024 Jan 31;12(2):331. doi: 10.3390/biomedicines12020331. Biomedicines. 2024. PMID: 38397933 Free PMC article.
High plateletcrit may be associated with thrombotic risk in polycythemia vera.
Krečak I, Zekanović I, Morić Perić M, Holik H, Coha B, Periša V, Lucijanić M. Krečak I, et al. Among authors: moric peric m. Int J Lab Hematol. 2023 Oct;45(5):799-801. doi: 10.1111/ijlh.14073. Epub 2023 Apr 12. Int J Lab Hematol. 2023. PMID: 37050866 No abstract available.
Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
Krečak I, Grohovac D, Vučenović Bašić N, Čeko M, Nižetić K, Sabljić A, Holik H, Galušić D, Zekanović I, Morić Perić M, Periša V, Lucijanić M. Krečak I, et al. Among authors: moric peric m. Thromb Res. 2023 Nov;231:141-143. doi: 10.1016/j.thromres.2023.03.004. Epub 2023 Mar 21. Thromb Res. 2023. PMID: 36964024 No abstract available.
25 results